ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Milbexime Anthelmintic Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27O17782
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Milbexime Anthelmintic Market Research Report 2024
BUY CHAPTERS

Global Milbexime Anthelmintic Market Research Report 2025

Code: QYRE-Auto-27O17782
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
Virbac SA
Krka
Zhejiang Hisun Pharmaceutical Co Ltd

Milbexime Anthelmintic Market Size

The global market for Milbexime Anthelmintic was valued at US$ 700 million in the year 2024 and is projected to reach a revised size of US$ 1040 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Milbexime Anthelmintic Market

Milbexime Anthelmintic Market

Similar to other macrolide antiparasitic drugs, milbexime acts as an agonist of GABA (γ-aminobutyric acid) neurotransmitter in nerve cells, and can also interact with gluten in nerve and muscle cells of invertebrates Amino acid-gated Cl-channel binding. In both cases, it blocks the parasite"s nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die. Milbexime also affects the reproductive activity of some parasites by reducing oviposition or inducing abnormal egg production.
North American market for Milbexime Anthelmintic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Milbexime Anthelmintic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Milbexime Anthelmintic include Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka, Zhejiang Hisun Pharmaceutical Co., Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Milbexime Anthelmintic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbexime Anthelmintic.
The Milbexime Anthelmintic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Milbexime Anthelmintic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Milbexime Anthelmintic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Milbexime Anthelmintic Market Report

Report Metric Details
Report Name Milbexime Anthelmintic Market
Accounted market size in year US$ 700 million
Forecasted market size in 2031 US$ 1040 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Single Ingredient
  • Compound Ingredients
Segment by Application
  • Cat
  • Dog
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka, Zhejiang Hisun Pharmaceutical Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Milbexime Anthelmintic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Milbexime Anthelmintic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Milbexime Anthelmintic Market growing?

Ans: The Milbexime Anthelmintic Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Milbexime Anthelmintic Market size in 2031?

Ans: The Milbexime Anthelmintic Market size in 2031 will be US$ 1040 million.

Who are the main players in the Milbexime Anthelmintic Market report?

Ans: The main players in the Milbexime Anthelmintic Market are Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka, Zhejiang Hisun Pharmaceutical Co., Ltd

What are the Application segmentation covered in the Milbexime Anthelmintic Market report?

Ans: The Applications covered in the Milbexime Anthelmintic Market report are Cat, Dog, Other

What are the Type segmentation covered in the Milbexime Anthelmintic Market report?

Ans: The Types covered in the Milbexime Anthelmintic Market report are Single Ingredient, Compound Ingredients

Recommended Reports

Antiparasitic & Deworming

Anthelmintic & Related APIs

Animal Drugs & Diagnostics

1 Milbexime Anthelmintic Market Overview
1.1 Product Definition
1.2 Milbexime Anthelmintic by Type
1.2.1 Global Milbexime Anthelmintic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Ingredient
1.2.3 Compound Ingredients
1.3 Milbexime Anthelmintic by Application
1.3.1 Global Milbexime Anthelmintic Market Value by Application (2024 VS 2031)
1.3.2 Cat
1.3.3 Dog
1.3.4 Other
1.4 Global Milbexime Anthelmintic Market Size Estimates and Forecasts
1.4.1 Global Milbexime Anthelmintic Revenue 2020-2031
1.4.2 Global Milbexime Anthelmintic Sales 2020-2031
1.4.3 Global Milbexime Anthelmintic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Milbexime Anthelmintic Market Competition by Manufacturers
2.1 Global Milbexime Anthelmintic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Milbexime Anthelmintic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Milbexime Anthelmintic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Milbexime Anthelmintic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Milbexime Anthelmintic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Milbexime Anthelmintic, Product Type & Application
2.7 Global Key Manufacturers of Milbexime Anthelmintic, Date of Enter into This Industry
2.8 Global Milbexime Anthelmintic Market Competitive Situation and Trends
2.8.1 Global Milbexime Anthelmintic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Milbexime Anthelmintic Players Market Share by Revenue
2.8.3 Global Milbexime Anthelmintic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Milbexime Anthelmintic Market Scenario by Region
3.1 Global Milbexime Anthelmintic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Milbexime Anthelmintic Sales by Region: 2020-2031
3.2.1 Global Milbexime Anthelmintic Sales by Region: 2020-2025
3.2.2 Global Milbexime Anthelmintic Sales by Region: 2026-2031
3.3 Global Milbexime Anthelmintic Revenue by Region: 2020-2031
3.3.1 Global Milbexime Anthelmintic Revenue by Region: 2020-2025
3.3.2 Global Milbexime Anthelmintic Revenue by Region: 2026-2031
3.4 North America Milbexime Anthelmintic Market Facts & Figures by Country
3.4.1 North America Milbexime Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Milbexime Anthelmintic Sales by Country (2020-2031)
3.4.3 North America Milbexime Anthelmintic Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Milbexime Anthelmintic Market Facts & Figures by Country
3.5.1 Europe Milbexime Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Milbexime Anthelmintic Sales by Country (2020-2031)
3.5.3 Europe Milbexime Anthelmintic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Milbexime Anthelmintic Market Facts & Figures by Region
3.6.1 Asia Pacific Milbexime Anthelmintic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Milbexime Anthelmintic Sales by Region (2020-2031)
3.6.3 Asia Pacific Milbexime Anthelmintic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Milbexime Anthelmintic Market Facts & Figures by Country
3.7.1 Latin America Milbexime Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Milbexime Anthelmintic Sales by Country (2020-2031)
3.7.3 Latin America Milbexime Anthelmintic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Milbexime Anthelmintic Market Facts & Figures by Country
3.8.1 Middle East and Africa Milbexime Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Milbexime Anthelmintic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Milbexime Anthelmintic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Milbexime Anthelmintic Sales by Type (2020-2031)
4.1.1 Global Milbexime Anthelmintic Sales by Type (2020-2025)
4.1.2 Global Milbexime Anthelmintic Sales by Type (2026-2031)
4.1.3 Global Milbexime Anthelmintic Sales Market Share by Type (2020-2031)
4.2 Global Milbexime Anthelmintic Revenue by Type (2020-2031)
4.2.1 Global Milbexime Anthelmintic Revenue by Type (2020-2025)
4.2.2 Global Milbexime Anthelmintic Revenue by Type (2026-2031)
4.2.3 Global Milbexime Anthelmintic Revenue Market Share by Type (2020-2031)
4.3 Global Milbexime Anthelmintic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Milbexime Anthelmintic Sales by Application (2020-2031)
5.1.1 Global Milbexime Anthelmintic Sales by Application (2020-2025)
5.1.2 Global Milbexime Anthelmintic Sales by Application (2026-2031)
5.1.3 Global Milbexime Anthelmintic Sales Market Share by Application (2020-2031)
5.2 Global Milbexime Anthelmintic Revenue by Application (2020-2031)
5.2.1 Global Milbexime Anthelmintic Revenue by Application (2020-2025)
5.2.2 Global Milbexime Anthelmintic Revenue by Application (2026-2031)
5.2.3 Global Milbexime Anthelmintic Revenue Market Share by Application (2020-2031)
5.3 Global Milbexime Anthelmintic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Elanco Animal Health
6.1.1 Elanco Animal Health Company Information
6.1.2 Elanco Animal Health Description and Business Overview
6.1.3 Elanco Animal Health Milbexime Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Elanco Animal Health Milbexime Anthelmintic Product Portfolio
6.1.5 Elanco Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim Animal Health
6.2.1 Boehringer Ingelheim Animal Health Company Information
6.2.2 Boehringer Ingelheim Animal Health Description and Business Overview
6.2.3 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product Portfolio
6.2.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Company Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Milbexime Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Animal Health Milbexime Anthelmintic Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 VIRBAC SA
6.4.1 VIRBAC SA Company Information
6.4.2 VIRBAC SA Description and Business Overview
6.4.3 VIRBAC SA Milbexime Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 VIRBAC SA Milbexime Anthelmintic Product Portfolio
6.4.5 VIRBAC SA Recent Developments/Updates
6.5 Krka
6.5.1 Krka Company Information
6.5.2 Krka Description and Business Overview
6.5.3 Krka Milbexime Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Krka Milbexime Anthelmintic Product Portfolio
6.5.5 Krka Recent Developments/Updates
6.6 Zhejiang Hisun Pharmaceutical Co., Ltd
6.6.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
6.6.2 Zhejiang Hisun Pharmaceutical Co., Ltd Description and Business Overview
6.6.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product Portfolio
6.6.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Milbexime Anthelmintic Industry Chain Analysis
7.2 Milbexime Anthelmintic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Milbexime Anthelmintic Production Mode & Process Analysis
7.4 Milbexime Anthelmintic Sales and Marketing
7.4.1 Milbexime Anthelmintic Sales Channels
7.4.2 Milbexime Anthelmintic Distributors
7.5 Milbexime Anthelmintic Customer Analysis
8 Milbexime Anthelmintic Market Dynamics
8.1 Milbexime Anthelmintic Industry Trends
8.2 Milbexime Anthelmintic Market Drivers
8.3 Milbexime Anthelmintic Market Challenges
8.4 Milbexime Anthelmintic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
Virbac SA
Krka
Zhejiang Hisun Pharmaceutical Co Ltd
List of Tables
 Table 1. Global Milbexime Anthelmintic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Milbexime Anthelmintic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Milbexime Anthelmintic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Milbexime Anthelmintic Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Milbexime Anthelmintic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Milbexime Anthelmintic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Milbexime Anthelmintic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Milbexime Anthelmintic Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Milbexime Anthelmintic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Milbexime Anthelmintic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Milbexime Anthelmintic, Product Type & Application
 Table 12. Global Key Manufacturers of Milbexime Anthelmintic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Milbexime Anthelmintic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Milbexime Anthelmintic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Milbexime Anthelmintic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Milbexime Anthelmintic Sales by Region (2020-2025) & (K Units)
 Table 18. Global Milbexime Anthelmintic Sales Market Share by Region (2020-2025)
 Table 19. Global Milbexime Anthelmintic Sales by Region (2026-2031) & (K Units)
 Table 20. Global Milbexime Anthelmintic Sales Market Share by Region (2026-2031)
 Table 21. Global Milbexime Anthelmintic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Milbexime Anthelmintic Revenue Market Share by Region (2020-2025)
 Table 23. Global Milbexime Anthelmintic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Milbexime Anthelmintic Revenue Market Share by Region (2026-2031)
 Table 25. North America Milbexime Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Milbexime Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 27. North America Milbexime Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 28. North America Milbexime Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Milbexime Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Milbexime Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Milbexime Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Milbexime Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Milbexime Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Milbexime Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Milbexime Anthelmintic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Milbexime Anthelmintic Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Milbexime Anthelmintic Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Milbexime Anthelmintic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Milbexime Anthelmintic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Milbexime Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Milbexime Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Milbexime Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Milbexime Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Milbexime Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Milbexime Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Milbexime Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Milbexime Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Milbexime Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Milbexime Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Milbexime Anthelmintic Sales (K Units) by Type (2020-2025)
 Table 51. Global Milbexime Anthelmintic Sales (K Units) by Type (2026-2031)
 Table 52. Global Milbexime Anthelmintic Sales Market Share by Type (2020-2025)
 Table 53. Global Milbexime Anthelmintic Sales Market Share by Type (2026-2031)
 Table 54. Global Milbexime Anthelmintic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Milbexime Anthelmintic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Milbexime Anthelmintic Revenue Market Share by Type (2020-2025)
 Table 57. Global Milbexime Anthelmintic Revenue Market Share by Type (2026-2031)
 Table 58. Global Milbexime Anthelmintic Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Milbexime Anthelmintic Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Milbexime Anthelmintic Sales (K Units) by Application (2020-2025)
 Table 61. Global Milbexime Anthelmintic Sales (K Units) by Application (2026-2031)
 Table 62. Global Milbexime Anthelmintic Sales Market Share by Application (2020-2025)
 Table 63. Global Milbexime Anthelmintic Sales Market Share by Application (2026-2031)
 Table 64. Global Milbexime Anthelmintic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Milbexime Anthelmintic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Milbexime Anthelmintic Revenue Market Share by Application (2020-2025)
 Table 67. Global Milbexime Anthelmintic Revenue Market Share by Application (2026-2031)
 Table 68. Global Milbexime Anthelmintic Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Milbexime Anthelmintic Price (US$/Unit) by Application (2026-2031)
 Table 70. Elanco Animal Health Company Information
 Table 71. Elanco Animal Health Description and Business Overview
 Table 72. Elanco Animal Health Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Elanco Animal Health Milbexime Anthelmintic Product
 Table 74. Elanco Animal Health Recent Developments/Updates
 Table 75. Boehringer Ingelheim Animal Health Company Information
 Table 76. Boehringer Ingelheim Animal Health Description and Business Overview
 Table 77. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product
 Table 79. Boehringer Ingelheim Animal Health Recent Developments/Updates
 Table 80. Merck Animal Health Company Information
 Table 81. Merck Animal Health Description and Business Overview
 Table 82. Merck Animal Health Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Animal Health Milbexime Anthelmintic Product
 Table 84. Merck Animal Health Recent Developments/Updates
 Table 85. VIRBAC SA Company Information
 Table 86. VIRBAC SA Description and Business Overview
 Table 87. VIRBAC SA Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. VIRBAC SA Milbexime Anthelmintic Product
 Table 89. VIRBAC SA Recent Developments/Updates
 Table 90. Krka Company Information
 Table 91. Krka Description and Business Overview
 Table 92. Krka Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Krka Milbexime Anthelmintic Product
 Table 94. Krka Recent Developments/Updates
 Table 95. Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
 Table 96. Zhejiang Hisun Pharmaceutical Co., Ltd Description and Business Overview
 Table 97. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product
 Table 99. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Milbexime Anthelmintic Distributors List
 Table 103. Milbexime Anthelmintic Customers List
 Table 104. Milbexime Anthelmintic Market Trends
 Table 105. Milbexime Anthelmintic Market Drivers
 Table 106. Milbexime Anthelmintic Market Challenges
 Table 107. Milbexime Anthelmintic Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Milbexime Anthelmintic
 Figure 2. Global Milbexime Anthelmintic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Milbexime Anthelmintic Market Share by Type: 2024 & 2031
 Figure 4. Single Ingredient Product Picture
 Figure 5. Compound Ingredients Product Picture
 Figure 6. Global Milbexime Anthelmintic Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Milbexime Anthelmintic Market Share by Application: 2024 & 2031
 Figure 8. Cat
 Figure 9. Dog
 Figure 10. Other
 Figure 11. Global Milbexime Anthelmintic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Milbexime Anthelmintic Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Milbexime Anthelmintic Sales (2020-2031) & (K Units)
 Figure 14. Global Milbexime Anthelmintic Average Price (US$/Unit) & (2020-2031)
 Figure 15. Milbexime Anthelmintic Report Years Considered
 Figure 16. Milbexime Anthelmintic Sales Share by Manufacturers in 2024
 Figure 17. Global Milbexime Anthelmintic Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Milbexime Anthelmintic Players: Market Share by Revenue in Milbexime Anthelmintic in 2024
 Figure 19. Milbexime Anthelmintic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Milbexime Anthelmintic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Milbexime Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 22. North America Milbexime Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 23. United States Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Milbexime Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 26. Europe Milbexime Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Milbexime Anthelmintic Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Milbexime Anthelmintic Revenue Market Share by Region (2020-2031)
 Figure 34. China Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Milbexime Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Milbexime Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Milbexime Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Milbexime Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Milbexime Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Milbexime Anthelmintic by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Milbexime Anthelmintic by Type (2020-2031)
 Figure 54. Global Milbexime Anthelmintic Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Milbexime Anthelmintic by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Milbexime Anthelmintic by Application (2020-2031)
 Figure 57. Global Milbexime Anthelmintic Price (US$/Unit) by Application (2020-2031)
 Figure 58. Milbexime Anthelmintic Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Milbemycin Oxime Market Research Report 2024
Global Flubendazole Market Research Report 2024
Global Antinematode Drugs Market Research Report 2024
Global γ Aminobutyric Acid Receptor Agonists Market Research Report 2025
Global Anti helminthic Drugs Market Research Report 2024
Global Moxidectin API Market Research Report 2024
Global Albendazole Tablets Market Research Report 2024
Global Mebendazole Market Research Report 2024
Neuromuscular Blocking Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GABA γ aminobutyric acid Market Insights Forecast to 2030
Global Butylscopolamine Bromide Market Research Report 2024
Global Anthelmintic Drugs Market Research Report 2024
Global Companion Animal Anthelmintics Market Research Report 2024
Global Vermox Market Research Report 2024
Global Animal Internal Parasiticide Market Insights Forecast to 2030
Global Milbemycin Oxime API Market Research Report 2025
Albendazole Anthelmintic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Anthelmintic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Valbazen Anthelmintic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Closantel Sodium Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions